Introduction
In unstimulated cells, a STAT protein exists in the cytoplasm as a monomer. Upon activation by tyrosine phosphorylation in response to ligand stimulation, STAT forms a dimer through SH2-phosphotyrosyl interactions (Becker et al., 1998; Chen et al., 1998; Shuai et al., 1994) . The STAT dimer then translocates into the nucleus to activate transcription. It is believed that the STAT dimer is dephosphorylated by an unidenti®ed protein tyrosine phosphatase (PTPase) to form non-phosphorylated STAT monomers in the nucleus (Darnell, 1997; Shuai, 1999) . The inactivated STAT monomer is relocated back to the cytoplasm where it can be reactivated, completing an activation-inactivation cycle (Figure 1 ). The hypothesis that a STAT can shuttle between cytoplasm and nucleus was initially derived from results of biochemical fractionation and pulse-chase experiments (Haspel and Darnell, 1999; Haspel et al., 1996) , and is clearly supported by recent studies using GFP (green¯uorescence protein) fusion proteins to visualize the tracking of Stat1 in living cells (Keoster and Hauser, 1999) . A number of proteins have been identi®ed that interact with STATs and modulate the activity of STATs at various steps of the activation-inactivation cycle ( Figure 1 ). The focus of this article is to review the roles of these STAT-interacting proteins in STAT signaling.
Interaction with non-STAT transcription factors
Studies on the promoters of a number of IFN-ainduced genes identi®ed a conserved DNA sequence named ISRE (interferon-a stimulated response element) that mediates IFN-a response (Darnell, 1997; Darnell et al., 1994) . Stat1 and Stat2, the ®rst known members of the STAT family, were identi®ed in the transcription complex ISGF-3 (interferon-stimulated gene factor 3) that binds to ISRE (Fu et al., 1990 . ISGF-3 consists of a Stat1:Stat2 heterodimer and a non-STAT protein named p48, a member of the IRF (interferon regulated factor) family (Levy, 1997) . p48 alone can bind to ISRE weakly. Although Stat1 and Stat2 can not bind to ISRE without p48, the ISGF3 complex has a high binding anity toward ISRE. The ISGF3 complex established a paradigm in which STAT proteins may aect transcription by modulating other non-STAT transcription factors. In fact, since STAT proteins were ®rst identi®ed through the characterization of ISGF3, it had been questioned whether STATs alone can bind to DNA. Characterization of IFN-g-induced gene activation demonstrated that Stat1 is a sequence speci®c DNA binding protein that drives transcription through GAS (g-activation site) (Decker et al., 1991; Shuai et al., 1992) . It now appears that a STAT protein may participate in transcriptional activation through four distinct mechanisms: (1) A STAT protein may bind to its own DNA target site to directly drive transcription; (2) A STAT protein may form a transcriptional complex with a non-STAT transcription factor to trigger transcription through a STAT; or (3) a non-STAT DNA binding element; (4) A STAT and a non-STAT transcription factor may cooperate to activate transcription through binding to clustered independent DNA binding sites (Figure 2 ).
p48
The molecular basis of ISGF3 complex formation has been extensively studied. Although Stat1, Stat2 and p48 can form a stable complex in the presence of DNA, initial attempts to detect association of Stat1 or Stat2 with p48 in solution had failed. Subsequently, in vivo coimmunoprecipitation studies using speci®c antibodies against p48 or Stat2 demonstrated that Stat2 can interact with p48 in the absence of DNA (Martinez-Moczygemba et al., 1997) . The Stat2-p48 interaction was detectable in cells with or without IFN-a treatment. But similar coimmunoprecipitation analysis failed to detect an interaction between Stat1 and p48. These results suggest that either Stat1 does not interact with p48 in solution in vivo, or alternatively, the interaction of p48 and Stat1 is weak and transient in the absence of the DNA target. Consistent with the latter hypothesis, the Stat1-p48 interaction was observed when analysed by the yeast two-hybrid assay, a highly sensitive method to detect protein-protein interactions. In addition, in vitro GST pull-down experiments suggested that both Stat1 and Stat2 can interact with p48, although the Stat2-p48 interaction is several fold stronger than the Stat1-p48 association .
In vitro reconstitution experiments identi®ed the COOH-terminal region of p48 (aa 217 ± 377) is required for ISGF3 formation (Veals et al., 1992) . Detailed domain mapping studies suggest that the NH2-terminal region of Stat1 (aa 152 ± 239) or Stat2 (aa 1 ± 324 in Stat2) contacts with the COOH-terminal portion of p48 ; Martinez-Moczygemba et al., 1997) (Figure 3) . The coiled-coil domain of Stat2 is essential for Stat2-p48 interaction. A single mutation (K161A) in the p48 contact region of Stat1 inhibited the Stat1-p48 interaction as well as the IFN-a-triggered ISG15 gene induction, whereas this mutation had no eect on either the Stat1-Stat2 interaction or the IFN-g response which is independent of p48 . These results strongly support the importance of the Stat1-p48 interaction in IFN-a signaling.
c-Jun and Sp1
It has been well established that the transcriptional activation of mammalian genes usually requires the The intercellular adhesion molecule-1 (ICAM-1) gene is induced by IFN-g. In the promoter of ICAM-1 gene, contiguous but independent DNA binding sites for Stat1 and Sp1 are present and are shown to be required for the full transcriptional activation of ICAM-1 gene in response to IFN-g. (Look et al., 1995) . Similarly, both a Stat3 binding sequence and an adjacent Sp1 binding site present in the promoter of the C/EBPd (CCAAT/enhancer binding protein d) gene are shown to be required for the induction of C/EBPd by IL-6 (Cantwell et al., 1998) . In addition, Stat1 and Sp1 association in solution has been observed. These studies demonstrate that Stat1 or Stat3 can cooperate with Sp1 to activate genes.
The involvement of Stat3 and c-Jun cooperation in transcriptional activation has been well documented for a number of genes, including the induction of a 2 -macroglobulin gene by IL-6 (Ito et al., 1989) , the induction of c-fos by multiple ligands (Robertson et al., 1995) , the induction of matrix metalloproteinase 1 gene by oncostatin M , and the induction of the vasoactive intestinal peptide gene by ciliary neurotrophic factor (Lewis et al., 1994) . The initial identi®cation that c-Jun interacts with Stat3 came from a yeast two-hybrid screen using the NH2-terminal segment of c-Jun as the bait (Schaefer et al., 1995 (Schaefer et al., , 1997 . It was found that Stat3b, a variant of Stat3, cooperates with c-Jun to activate the transcription of the a 2 -macroglobulin gene. Detailed Stat3-c-Jun interaction studies have recently been reported (Zhang et al., 1999) . The COOH-terminal region of c-Jun (aa 105 ± 334) is shown to interact with two regions in the NH2-terminal portion of Stat3 (aa 130 ± 358). One region is within the coiled-coid domain of Stat3, whereas the other region is located in the DNA binding domain but distant from DNA contact sites of Stat3 
Glucocortical receptor
The ®nding that glucocorticoid receptor (GR) is associated with Stat5 came from studies on the bcasein gene. Upon interaction with its steroid ligand, GR binds to speci®c DNA sequence, the glucocorticoid response element (GRE) to activate transcription (Beato et al., 1995) . The optimal expression of b-casein gene is achieved when costimulated with glucocorticoids and prolactin (PRL), a growth hormone that activates Stat5 (Schmitt-Ney et al., 1991) . A functional Stat5 binding site and halfpalindromic GREs are present in the promoter of bcasein gene. Mutation of the Stat5 binding site in the b-casein gene promoter abolishes both glucocorticoid-and PRL-induced transcription. In vivo coimmunoprecipitation studies detected a physical association between Stat5 with GR (Cella et al., 1998; Steocklin et al., 1996) . In addition, GR is present in PRL-induced Stat5 DNA-binding complex and can enhance Stat5-mediated transcription. It has been suggested that GR may act as a transcriptional co-activator for Stat5 (Steocklin et al., 1996) . Interestingly, a recent report suggests that cotransfection of GR and Stat5 resulted in the enhancement of the DNA binding activity and the tyrosine phosphorylation of Stat5 (Wyszomierski et al., 1999) . It will be of great interest to understand the molecular basis of the observed eect of GR on Stat5 activation and to examine if the enhanced tyrosine phosphorylation of Stat5 by GR is solely responsible for the transcriptional synergy exhibited by Stat5 and GR. Interaction with p300/CBP and Nmi p300/CBP STATs, like many signal-responsive transcriptional factors, are found to be regulated by coactivators p300 and CBP (Bhattacharya et al., 1996; Horvai et al., 1997; Zhang et al., 1996) , the histone acetyltransferases involved in chromatin remodeling (Kadonaga, 1998) . Stat2 was identi®ed as a candidate protein that interacts with the cysteine-histidine-rich domain 1 (CH1) of p300 in an expression screen. The p300/ CBP interactive region of Stat2 is located at the COOH-terminal portion of Stat2 that functions as a transcriptional activation domain (Figure 3 ). Stat1 has also been shown to interact with p300/CBP through two separate regions: the NH2-terminal region of Stat1 interacts with the CREB-binding domain of p300/CBP and the COOH-terminal region of Stat1 interacts with the CH3 domain of p300/CBP that is also known to bind to adenovirus E1A protein (Figure 3 ). Because p300/CBP is required for E1A to activate transcription during viral replication and cellular transformation by adenovirus, these results suggest that E1A may interfere with the anti-viral activity of IFNs by competing for binding to p300/CBP. Indeed, wild type E1A, but not mutant E1A defective in binding to p300/ CBP, is able to inhibit IFN-induced STAT-dependent transcription. Thus, p300 and CBP potentiate STATmediated transcription by linking STAT to the basal transcriptional machinery. The interruption of STATp300/CBP interactions by E1A contributes to adenovirus survival in its natural host.
Nmi
Nmi (N-Myc interactor) was ®rst identi®ed through a yeast two-hybrid screen using the COOH-terminus of N-Myc that includes the bHLH-Zip (basic helix ± loop ± helix/leucine zipper) region as the bait (Bao and Zervos, 1996) . In addition to N-Myc, Nmi was shown to be able to interact with c-myc and Max (contain a bHLH-Zip domain), daughterless (contains a bHLH domain), and c-fos (contains a bZip motif) in yeast two-hybrid assays. Interaction of Nmi with N-Myc or c-myc was also detected when overexpressed in 293 cells. The human Nmi is a protein of 307 amino acids. Sequence analysis suggests that the NH2-terminus of Nmi contains a coiled-coil heptad repeat, whereas its COOH-terminal region shows homology to an interferon-induced leucine zipper protein, IP35 (Bao and Zervos, 1996) . Subsequent studies indicate that Nmi expression is also interferon-inducible (Lebrun et al., 1998) .
In an independent yeast two-hybrid screen using the coiled-coil region (aa 182 ± 337) of Stat5b as the bait, Nmi was identi®ed as a Stat5-interacting protein (Zhu et al., 1999) . The expression of Nmi is inducible by IL-2 in peripheral blood lymphocytes (PBL). Nmi and Stat5 association was detected in PBL cells with or without IL-2 treatment by in vivo coimmunoprecipitation analysis. Detailed mapping studies indicate that two regions of Nmi (aa 57 ± 99 and aa 143 ± 202) are able to interact with the amino acid 232 ± 321 region of Stat5b (Figure 3) . The importance of Nmi in IL-2-activated Stat5 signaling was suggested by transient luciferase reporter assays. An antisense Nmi expression vector can inhibit IL-2-induced Stat5 luciferase reporter in YT cells, while a sense Nmi expression reporter can enhance Stat5-mediated gene activation in an IL-2 responsive NIH3T3-derived cell line. Interestingly, Nmi was found to augment the association of Stat5 with CBP. These results strongly suggest that Nmi may function to enhance the transcriptional activity of Stat5 by augmenting the recruitment of CBP to Stat5. Furthermore, in vitro GST pull-down analysis indicates that all STATs except Stat2 can interact with Nmi. Consistently, Nmi can enhance IFN-g-dependent Stat1-mediated transcription.
In contrast to the proposed nuclear function of Nmi, several studies indicate that Nmi is a cytoplasmic protein (Bannasch et al., 1999; Lebrun et al., 1998; Lee et al., 1999) . The endogenous Nmi or ectopically expressed full-length Nmi was found to be localized in the cytoplasm, in punctate speckles, in a number of cell lines. Although these studies can not exclude the possibility that a small fraction of Nmi is present in the nucleus, it seems likely that Nmi may function mainly in the cytoplasm. Alternatively, Nmi may shuttle between cytoplasm and nucleus and may reside in the nucleus transiently due to fast nuclear export. Further experiments are needed to solve this discrepancy.
Protein inhibitors of activated STAT

Isolation of the PIAS family of proteins
In a yeast two-hybrid screen aimed at the identi®cation of potential regulators of Stat1, a partial cDNA clone encoding the COOH-terminal region of an unknown protein, which later named as PIAS1 (protein inhibitor of activated Stat1), was isolated based on its ability to interact with Stat1b (Liu et al., 1998; Shuai, 1999) . In the process of characterizing PIAS1 in Stat1 signaling, a protein named GBP (Gu binding protein) that is highly related to PIAS1 was reported to bind to Gu RNA helicase (Valdez et al., 1997) . The major dierence between PIAS1 and GBP is that GBP lacks the NH2-terminal 9 amino acid residues present in PIAS1 (if the ®rst methione residue present in GBP protein sequence is counted as the ®rst amino acid of GBP). Subsequent studies suggest that the NH2-terminal 9 amino acid residues of PIAS1 is essential for PIAS1 function (Liu and Shuai, unpublished data) . It is possible that GBP represents an incomplete version of PIAS1.
Four additional mammalian proteins related to PIAS1 were identi®ed through database search and cDNA library screen (Chung et al., 1997; Liu et al., 1998) : PIAS3, PIASy, PIASxa, and PIASxb. Sequence analysis suggests that PIAS3 and PIASy are novel proteins. PIASxa and PIASxb are identical, except they have distinct COOH-terminal regions, and are probably the products of dierentially spliced messages from the same gene. An incomplete portion of PIASxb (aa 134 ± 621), named as Miz1, was previously shown to interact with a homeobox DNA binding protein Msx2 (Wu et al., 1997) .
EST clones encoding proteins that have sequence homology with PIAS are also found in Drosophila, C. elegans, yeast, and plants. Zimp, the Drosophila PIAS homologue, is found to be essential in Drosophila development (Mohr and Boswell, 1999) .
The structure of PIAS
Sequence analysis reveals several interesting structure features of the PIAS family of proteins (Figure 4) . A conserved putative LXXLL signature motif is present in the NH2-terminal region of all PIAS proteins. The LXXLL motif, also known as NR (nuclear receptor) box, is found to be present in a number of nuclear receptor coregulators (Heery et al., 1997; Torchia et al., 1997 Torchia et al., , 1998 . The LXXLL signature motif mediates ligand-dependent coactivator-nuclear receptor interactions or coactivator-coactivator interactions. A putative zinc binding motif is present near the middle of PIAS proteins. The COOH-terminal regions of PIAS proteins are least conserved and consist of a highly acidic region and a serine/threonine rich region. Interestingly, unlike other PIAS proteins, PIASy lacks the COOH-terminal serine/threonine rich domain. The roles of these domains in PIAS function remain to be determined.
PIAS1 and PIAS3 as inhibitors of STAT signaling
In vivo coimmunoprecipitation studies using speci®c antibodies against PIAS1 and PIAS3 indicated that PIAS1 and PIAS3 interacts with Stat1 and Stat3, respectively (Chung et al., 1997; Liu et al., 1998) . Most interestingly, the PIAS-STAT interaction is dependent on cytokine stimulation. In vitro DNA binding analysis suggests that PIAS can block the DNA binding activity of STAT. Consistently, PIAS can inhibit STATmediated gene activation. Thus, these results suggest that PIAS1 and PIAS3 are inhibitors of Stat1 and Stat3.
The observation that PIAS is associated with STAT only in cells stimulated with cytokines suggests that the PIAS-STAT interaction may be regulated. Deletional analysis indicates that a region immediately after the zinc binding motif of PIAS1 interacts with the NH2-terminal portion (aa 1 ± 191) of Stat1 (Figure 3) . A mutant PIAS1 lacking the Stat1 interactive domain is defective in suppressing Stat1-mediated gene activation (Liao et al., 2000, submitted) .
Interaction with MCM5
The transcriptional activation domain (TAD) of Stat1 is localized at the COOH-terminal region (Darnell, 1997) . Phosphorylation at Ser727 in the Stat1 TAD domain is required for the maximal transcriptional activity of Stat1 (Wen et al., 1995) . Using GST-TAD in protein-trapping assays, a group of nuclear proteins speci®cally associated with TAD were identi®ed (Zhang et al., 1998) . One of these nuclear proteins has been identi®ed as MCM5, a member of the minichromosome maintenance (MCM) family of proteins known to be involved in DNA replication (Dutta and Bell, 1997) . Interestingly, the interaction of MCM5 with the Stat1 TAD domain is Ser727-dependent. The substitution of Ser727 with Ala inhibited the association. Most importantly, MCM5 can enhance Stat1-mediated reporter gene assays. These results strongly suggest the importance of MCM5-Stat1 interaction in regulating the transcriptional activity of Stat1. MCM proteins have helicase activity and are known to associate with initiation and elongation complexes during DNA replication (Dutta and Bell, 1997) . Thus, it seems likely that MCM5 may play a dual role in DNA replication and Stat1-mediated gene transcription.
Interaction with NPI-1
One important feature of STAT activation is the rapid nuclear translocation of STAT upon ligand stimulation. The formation of the nuclear pore-targeting complex (PTAC) in the cytoplasm is required for the translocation of nuclear localization signal (NSL)-containing proteins (Imamoto et al., 1995) . The PTAC complex consists of a karyophilic protein and two essential a and b subunit families (Sekimoto and Yoneda, 1998) . Studies on the nuclear translocation of Stat1 have identi®ed a physical association of Stat1 with NPI-1, a member of the a subunit family (Sekimoto et al., 1997) . The binding of Stat1 to NPI-1 allows an indirect association of Stat1 with the b subunit. Interestingly, in vitro binding assays suggest that NPI-1 can trap Stat1 only when extracts from cells stimulated with IFN-g were used, suggesting the interaction of NPI-1 and Stat1 may be regulated. Stat1 contacts the COOH-terminal portion of NPI-1, a region distinct from the SV40 large T antigen NLSbinding domain. The NPI-1 interacting region of Stat1 has not been identi®ed. Microinjection of antibodies against NPI-1 or b subunit eectively blocked the nuclear translocation of Stat1. These results demonstrate the importance of NPI-1 and Stat1 interaction in the regulation of Stat1 nuclear translocation.
Interaction with ERKs
Several STATs can be serine phosphorylated through ERK-dependent and -independent mechanisms (see review by T Decker in this issue). Growth hormone (GH) can induce the activation of Stat5 and ERK pathways (Pircher et al., 1997; Winston and Bertics, 1992) . It has been shown that Stat5a which contains a putative ERK phosphorylation site (RLSP) is physically associated with ERK1/2 (Pircher et al., 1999) . The ERK interaction region of Stat5a is mapped at the COOH-terminal portion of Stat5a (Figure 3) . It is proposed that the association of Stat5a with ERK results in the phosphorylation of Stat5a at Ser780 by 
Conclusion
A growing number of STAT-interacting proteins have been described. These proteins have distinct functions in the modulation of STAT signaling. What is the signi®cance of STAT-interacting proteins in STAT signaling? First, STAT-interacting proteins can function as positive or negative factors to regulate various basic aspects of STAT signaling. For example, STAT-interacting kinases/phosphatases directly aect the activation/inactivation process of STATs; p300/ CBP links STATs to the basal transcriptional machinery; the relative level of STATs and PIAS proteins for a given cell type may aect the overall strength of STAT signaling. Second, since STATs play important roles in numerous fundamental cellular processes, the involvement of other non-STAT transcription factors certainly contributes to the speci®city and complexity of STAT-mediated gene activation. Indeed, many of the STAT-interacting proteins identi®ed so far are directly involved in the regulation of the transcriptional activity of STATs.
Third, crosstalk between STAT and other cellular signaling pathways can be achieved by the action of certain STAT-associated proteins. For example, an interaction between ERK and STAT may connect the MAPK and STAT signaling pathways. Members of the PIAS family have also been suggested to function in androgen signaling (Moilanen et al., 1999; Tan et al., 2000) .
The NH2-and the COOH-terminal regions of STATs are largely responsible for mediating proteinprotein interactions (Figure 3 ). Since the binding sites for many STAT-interacting proteins are overlap, it seems likely that multiple STAT complexes may exist in vivo. Recent studies have suggested the presence of high molecular mass Stat3-containing complexes in the cytosol (Ndubuisi et al., 1999) . The chaperone GRP58/ ER-60/ERp57 was identi®ed as a component of the large complex. The involvement of scaold proteins in the formation of large signaling complexes, the socalled`signalsome', has been suggested in several signaling pathways (Cohen et al., 1998; Whitmarsh et al., 1998) .
The physiological importance of many STATinteracting proteins as well as the molecular basis of their interactions with STATs remain to be determined. Since the dysregulation of STAT activity appears to contribute to certain human diseases and cancer, future studies on STAT-interacting proteins may enhance our ability to design rational therapeutic strategies.
